New drug cocktail aims to beat tough infection in HIV patients
NCT ID NCT07585461
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This trial tests whether adding a fluoroquinolone antibiotic to the standard three-drug treatment helps HIV patients with a serious bacterial infection called disseminated MAC. About 124 adults will be randomly assigned to get either the standard therapy or the four-drug combo for the first 8 weeks. The main goal is to see if more patients feel better by day 28, with fewer fevers and improved symptoms.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- fluoroquinolone (levofloxacin or moxifloxacin) added to standard triple therapy
- What this could lead to
- If it works, this could lead to a more effective treatment for HIV patients with severe MAC infections, improving early recovery and reducing bacterial load.
- What could go wrong
- This is an early-stage trial with only 124 participants, so results may not apply to everyone. Adding a fluoroquinolone also raises risks like heart rhythm problems and side effects.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DISSEMINATED MYCOBACTERIUM AVIUM COMPLEX INFECTION are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a new strategy break the cycle of HIV care dropout?
- A One-Two punch against cervical cancer: testing plus vaccination in HIV-Positive women
- Smart pill bottles and health coaches team up to tackle HIV in the deep south
- Can one Mega-Dose of an antifungal beat a deadly infection in AIDS patients?
- Can Long-Acting HIV shots outperform daily pills during lymphoma treatment?
- Immune-Boosting cocktail aims to free HIV patients from daily medication